Pliant Therapeutics Inc

NASDAQ:PLRX

1.59

-0.06 (-3.64%)

7:40:54 PM EDT: $1.57 -0.02 (-1.26%)

Pliant Therapeutics Inc Stock, NASDAQ:PLRX

260 Littlefield Avenue, South San Francisco, California 94080

United States of America

Phone: +1.650.481.6770

Number of Employees: 171

http://www.pliantrx.com

Description

Pliant Therapeutics, Inc. engages in the discovery and development of therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-Ã?Å?1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.